Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:51:09.676Z.
Calculation as of: 2026-10-06T22:51:09.676Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4a4fa98aa52f375fdc5874331a43a09dc7975e501838f67450551c218d6975f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-11-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
10.21x
EV/EBITDA RATIO AVG 3Y
10.21x
EV/EBITDA RATIO AVG 5Y
10.68x
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
EyePoint Pharmaceuticals, Inc.
Market Cap
$265.78M
EV/EBITDA Ratio
N/A
TTM Avg
10.21x
3Y Avg
10.21x
5Y Avg
10.68x
Market Cap
$266.59M
EV/EBITDA Ratio
N/A
TTM Avg
71.43x
3Y Avg
71.43x
5Y Avg
71.43x
Market Cap
$262.92M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.43M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$270.80M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$271.81M
EV/EBITDA Ratio
N/A
TTM Avg
15.28x
3Y Avg
21.84x
5Y Avg
24.53x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $265.78M | N/A | 10.21x | 10.21x | 10.68x |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | N/A | 71.43x | 71.43x | 71.43x |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | N/A | N/A | N/A | N/A |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | N/A | N/A | N/A | N/A |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | N/A | 15.28x | 21.84x | 24.53x |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A | 2.41x | 3817.71x | 2177.76x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2015-11-06 | 12.69x |
| 2015-11-05 | 13.21x |
| 2015-11-04 | 13.05x |
| 2015-11-03 | 12.85x |
| 2015-11-02 | 12.93x |
| 2015-10-30 | 12.85x |
| 2015-10-29 | 12.81x |
| 2015-10-28 | 12.89x |
| 2015-10-27 | 12.48x |
| 2015-10-26 | 12.93x |
| 2015-10-23 | 12.97x |
| 2015-10-22 | 13.17x |
| 2015-10-21 | 13.01x |
| 2015-10-20 | 13.49x |
| 2015-10-19 | 13.25x |
| 2015-10-16 | 13.37x |
| 2015-10-15 | 12.81x |
| 2015-10-14 | 12.16x |
| 2015-10-13 | 12.44x |
| 2015-10-12 | 12.69x |
| 2015-10-09 | 12.65x |
| 2015-10-08 | 12.36x |
| 2015-10-07 | 12.36x |
| 2015-10-06 | 12.69x |
| 2015-10-05 | 12.77x |
| 2015-10-02 | 12.20x |
| 2015-10-01 | 11.84x |
| 2015-09-30 | 12.08x |
| 2015-09-29 | 11.72x |
| 2015-09-28 | 12.65x |
| 2015-09-25 | 11.52x |
| 2015-09-24 | 11.92x |
| 2015-09-23 | 12.20x |
| 2015-09-22 | 12.28x |
| 2015-09-21 | 12.48x |
| 2015-09-18 | 12.97x |
| 2015-09-17 | 13.17x |
| 2015-09-16 | 12.52x |
| 2015-09-15 | 13.37x |
| 2015-09-14 | 12.81x |
| 2015-09-11 | 12.81x |
| 2015-09-10 | 10.27x |
| 2015-09-09 | 10.51x |
| 2015-09-08 | 10.44x |
| 2015-09-04 | 10.13x |
| 2015-09-03 | 10.13x |
| 2015-09-02 | 10.06x |
| 2015-09-01 | 10.06x |
| 2015-08-31 | 10.27x |
| 2015-08-28 | 10.93x |
| 2015-08-27 | 10.34x |
| 2015-08-26 | 10.41x |
| 2015-08-25 | 10.20x |
| 2015-08-24 | 10.44x |
| 2015-08-21 | 11.10x |
| 2015-08-20 | 11.20x |
| 2015-08-19 | 11.41x |
| 2015-08-18 | 11.31x |
| 2015-08-17 | 11.34x |
| 2015-08-14 | 11.31x |
| 2015-08-13 | 11.48x |
| 2015-08-12 | 11.48x |
| 2015-08-11 | 11.38x |
| 2015-08-10 | 11.31x |
| 2015-08-07 | 11.24x |
| 2015-08-06 | 11.27x |
| 2015-08-05 | 11.31x |
| 2015-08-04 | 11.38x |
| 2015-08-03 | 11.31x |
| 2015-07-31 | 11.34x |
| 2015-07-30 | 11.34x |
| 2015-07-29 | 11.76x |
| 2015-07-28 | 11.55x |
| 2015-07-27 | 11.48x |
| 2015-07-24 | 11.38x |
| 2015-07-23 | 11.45x |
| 2015-07-22 | 11.52x |
| 2015-07-21 | 11.62x |
| 2015-07-20 | 11.31x |
| 2015-07-17 | 11.31x |
| 2015-07-16 | 12.10x |
| 2015-07-15 | 12.24x |
| 2015-07-14 | 12.76x |
| 2015-07-13 | 12.17x |
| 2015-07-10 | 11.41x |
| 2015-07-09 | 10.86x |
| 2015-07-08 | 9.37x |
| 2015-07-07 | 10.06x |
| 2015-07-06 | 10.34x |
| 2015-07-02 | 10.41x |
| 2015-07-01 | 10.44x |
| 2015-06-30 | 10.34x |
| 2015-06-29 | 9.99x |
| 2015-06-26 | 10.48x |
| 2015-06-25 | 10.65x |
| 2015-06-24 | 11.14x |
| 2015-06-23 | 11.14x |
| 2015-06-22 | 11.24x |
| 2015-06-19 | 11.31x |
| 2015-06-18 | 11.20x |
| 2015-06-17 | 10.34x |
| 2015-06-16 | 10.30x |
| 2015-06-15 | 10.30x |
| 2015-06-12 | 10.55x |
| 2015-06-11 | 10.58x |
| 2015-06-10 | 10.62x |
| 2015-06-09 | 10.62x |
| 2015-06-08 | 10.89x |
| 2015-06-05 | 10.89x |
| 2015-06-04 | 10.69x |
| 2015-06-03 | 10.79x |
| 2015-06-02 | 10.62x |
| 2015-06-01 | 10.65x |
| 2015-05-29 | 10.89x |
| 2015-05-28 | 10.82x |
| 2015-05-27 | 10.72x |
| 2015-05-26 | 10.93x |
| 2015-05-22 | 11.17x |
| 2015-05-21 | 11.24x |
| 2015-05-20 | 11.24x |
| 2015-05-19 | 11.48x |
| 2015-05-18 | 11.10x |
| 2015-05-15 | 11.20x |
| 2015-05-14 | 11.27x |
| 2015-05-13 | 10.79x |
| 2015-05-12 | 10.96x |
| 2015-05-11 | 10.65x |
| 2015-05-08 | 7.55x |
| 2015-05-07 | 8.76x |
| 2015-05-06 | 8.74x |
| 2015-05-05 | 7.91x |
| 2015-05-04 | 7.88x |
| 2015-05-01 | 7.65x |
| 2015-04-30 | 7.62x |
| 2015-04-29 | 7.83x |
| 2015-04-28 | 7.91x |
| 2015-04-27 | 7.86x |
| 2015-04-24 | 8.14x |
| 2015-04-23 | 7.93x |
| 2015-04-22 | 7.83x |
| 2015-04-21 | 7.93x |
| 2015-04-20 | 7.88x |
| 2015-04-17 | 7.70x |
| 2015-04-16 | 7.88x |
| 2015-04-15 | 7.91x |
| 2015-04-14 | 7.96x |
| 2015-04-13 | 8.25x |
| 2015-04-10 | 8.09x |
| 2015-04-09 | 7.99x |
| 2015-04-08 | 7.78x |
| 2015-04-07 | 7.78x |
| 2015-04-06 | 7.68x |
| 2015-04-02 | 7.34x |
| 2015-04-01 | 7.34x |
| 2015-03-31 | 7.60x |
| 2015-03-30 | 7.65x |
| 2015-03-27 | 7.81x |
| 2015-03-26 | 7.91x |
| 2015-03-25 | 8.12x |
| 2015-03-24 | 8.66x |
| 2015-03-23 | 8.63x |
| 2015-03-20 | 8.50x |
| 2015-03-19 | 8.63x |
| 2015-03-18 | 8.58x |
| 2015-03-17 | 8.66x |
| 2015-03-16 | 8.56x |
| 2015-03-13 | 8.50x |
| 2015-03-12 | 8.74x |
| 2015-03-11 | 8.76x |
| 2015-03-10 | 8.71x |
| 2015-03-09 | 8.94x |
| 2015-03-06 | 8.94x |
| 2015-03-05 | 9.02x |
| 2015-03-04 | 9.20x |
| 2015-03-03 | 9.07x |
| 2015-03-02 | 9.02x |
| 2015-02-27 | 8.76x |
| 2015-02-26 | 8.94x |
| 2015-02-25 | 8.89x |
| 2015-02-24 | 8.92x |
| 2015-02-23 | 8.92x |
| 2015-02-20 | 9.02x |
| 2015-02-19 | 9.23x |
| 2015-02-18 | 8.87x |
| 2015-02-17 | 8.74x |
| 2015-02-13 | 8.22x |
| 2015-02-12 | 7.91x |
| 2015-02-11 | 7.88x |
| 2015-02-10 | 7.88x |
| 2015-02-09 | 7.88x |
| 2015-02-06 | 9.41x |
| 2015-02-05 | 9.05x |
| 2015-02-04 | 9.18x |
| 2015-02-03 | 9.05x |
| 2015-02-02 | 8.87x |
| 2015-01-30 | 9.02x |
| 2015-01-29 | 9.15x |
| 2015-01-28 | 9.20x |
| 2015-01-27 | 9.59x |
| 2015-01-26 | 9.54x |
| 2015-01-23 | 9.59x |
| 2015-01-22 | 9.51x |
| 2015-01-21 | 9.51x |
| 2015-01-20 | 9.64x |
| 2015-01-16 | 9.51x |
| 2015-01-15 | 9.33x |
| 2015-01-14 | 9.54x |
| 2015-01-13 | 9.28x |
| 2015-01-12 | 9.41x |
| 2015-01-09 | 9.54x |
| 2015-01-08 | 9.56x |
| 2015-01-07 | 9.46x |
| 2015-01-06 | 9.41x |
| 2015-01-05 | 9.62x |
| 2015-01-02 | 9.77x |
| 2014-12-31 | 9.64x |
| 2014-12-30 | 9.67x |
| 2014-12-29 | 9.67x |
| 2014-12-26 | 9.41x |
| 2014-12-24 | 9.36x |
| 2014-12-23 | 9.44x |
| 2014-12-22 | 9.92x |
| 2014-12-19 | 10.05x |
| 2014-12-18 | 9.92x |
| 2014-12-17 | 9.62x |
| 2014-12-16 | 9.59x |
| 2014-12-15 | 9.90x |
| 2014-12-12 | 10.39x |
| 2014-12-11 | 10.36x |
| 2014-12-10 | 10.70x |
| 2014-12-09 | 10.75x |
| 2014-12-08 | 10.31x |
| 2014-12-05 | 10.54x |
| 2014-12-04 | 10.18x |
| 2014-12-03 | 10.39x |
| 2014-12-02 | 10.39x |
| 2014-12-01 | 10.03x |
| 2014-11-28 | 10.16x |
| 2014-11-26 | 10.36x |
| 2014-11-25 | 10.03x |
| 2014-11-24 | 9.49x |
| 2014-11-21 | 9.10x |
| 2014-11-20 | 9.10x |
| 2014-11-19 | 8.28x |
| 2014-11-18 | 8.33x |
| 2014-11-17 | 8.30x |
| 2014-11-14 | 8.51x |
| 2014-11-13 | 8.25x |
| 2014-11-12 | 8.69x |
| 2014-11-11 | 8.35x |
| 2014-11-10 | 8.64x |
| 2011-09-13 | 12.75x |
| 2011-09-12 | 12.75x |
| 2011-09-09 | 13.17x |
| 2011-09-08 | 13.52x |
| 2011-09-07 | 13.45x |
| 2011-09-06 | 13.10x |
| 2011-09-02 | 13.20x |
| 2011-09-01 | 13.17x |
| 2011-08-31 | 13.24x |
Showing the most recent 260 of 684 data points. The chart above shows the full history.
